YD Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
EBITDA | -2,216 | -3,365 | 417 | 2,177 |
Net Income | -2,214 | -3,367 | 417 | 2,189 |
Free Cash Flow | -298 | -490 | -365 | -21 |
Cash | 6 | 3,132 | ||
Basic Shares | 3,409 | 3,419 | 4,033 | 4,033 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 |
|---|---|---|
Revenue | $510 | $350 |
Gross Profit | 155 | 153 |
EBITDA | -1,280 | 22 |
EBIT | -1,385 | 19 |
Net Income | -1,411 | 13 |
Net Change In Cash | 510 | 350 |
Free Cash Flow | -4,747 | -55 |
Cash | 3,132 | 87 |
Basic Shares | 4,145 | 70,095 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.64 |
2025-03-31 | -$1.10 |
2024-12-31 | $0.10 |
2024-09-30 | -$0.16 |
